This site is intended for Healthcare Professionals only.

Cloral betaine 707mg tablets to remain out of stock until November

Date:

Share post:

Cloral betaine 707mg tablets are out of stock and are expected to return to the pharmacy shelves in November, the product manufacturer Marlborough Pharmaceuticals has said.

To substitute the tablets, supply of an alternative imported unlicensed medicinal product (specials) is available through Alliance Healthcare Specials with PIP code: 802-0745.

“A prescription for a pack of 30 x Cloral betaine 707mg tablets submitted for payment in the dispensing month of September would be reimbursed at the Drug Tariff (September 2020) list price of £138.59,” the Pharmaceutical Services Negotiating Committee (PSNC) has said in an advice to pharmacies.

The unlicensed alternative available via Alliance Healthcare Specials is currently available to purchase at a higher price than the equivalent licensed product.

“Where the prescribing of a special is considered appropriate by the prescriber, a prescription must be issued with the wording ‘special order’ next to the prescribed product to ensure that a pharmacy can dispense and be correctly reimbursed for a non-Part VIIIB special,” the pharmacy body has suggested.

There is currently no NHS Dictionary of Medicines and Devices (dm+d) Actual Medicinal Product (AMP) listing for the specials product for prescribers to select using their prescribing systems so a prescription for unlicensed Cloral betaine 707mg tablets cannot be issued using EPS.

PSNC has submitted a request to Department of Health and Social Care (DHSC) seeking the addition of the unlicensed ‘special order‘ listing of Cloral betaine 707mg tablets to dm+d.

Until the listing has been added to dm+d, where a prescriber wishes to prescribe the special, a paper FP10 prescription should be issued as ‘Cloral betaine 707mg tablets (special order) and endorsed by the pharmacy as a non-Part VIIIB special

All paper FP10 prescriptions for unlicensed medicines should be placed in the red separators for the end of month submission, the PSNC said.

“All unlicensed medicinal products (specials) automatically qualify for group item discount not deducted (DND) status meaning that no discount deduction will be applied to their reimbursement prices”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce The...

New NHS patient choice scheme offers 5 options, but nursing shortages persist

Royal College of Nursing CE urges caution amidst new NHS patient choice pilot scheme rollout "Patients deserve choice, but...

Prof Ryan Donnelly awarded prestigious RPS Harrison Memorial Medal 2024

RPS HMM winner Professor Donnelly's work has secured £30M+ funding through his pioneering work in developing advanced polymeric...

Pharmacies forced to subsidise NHS medicines: NPA hands £108m invoice to DHSC

The NPA calls for a new deal that reverses “historical funding cuts and gives the sector the respect...